REICH KRISTIAN (Chief Scientific Officer) sold 1.6% of their position (43.70K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $877.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/21/2026ACC: 0001213900-26-080133
Officer· Chief Scientific Officer
Since Apr 2022
-43.70K
Net shares
Net seller
$877.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
43.70K disposed
Non-Derivative Transactions1
Class A ordinary shares, par value $0.0001 per share
Indirect
Shares
−43.70K
Price / share
$20.09
Trade value
$877.93K
% of position
1.6%
7/20/2026
2.81M→2.76M
Total
Net shares
−43.70K
Net value
-$877.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Indirect | 7/20/2026 | S · Sale | −43.70K | $20.09 | $877.93K | 1.6% | 2.81M | 2.76M |
| Total | −43.70K | -$877.93K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A ordinary shares, par value $0.0001 per share
DirectShares owned35.39K
Total
35.39K direct35.39K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A ordinary shares, par value $0.0001 per share | 35.39K | Direct |
| Total | 35.39K | 35.39K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported